Just yesterday, Bryan Johnson, the fintech founder-turned-longevity figurehead, announced Immortals—a health program priced at $1 million per year with only three available spots. Johnson describes it as “the world’s best health program” and the exact protocol behind his widely publicized anti-aging regimen, now packaged as a fully managed service.
The $1 million tier covers:
Johnson says lower-cost tiers are coming: a $60,000 “supported” option and a free digital version, with the stated long-term goal of universal access regardless of income.

Longevity medicine has become a growth industry. Fountain Life offers its APEX membership at $21,500 a year, and Biograph its most premium tier at $15,000. But $1 million is a different category entirely.
More transparent about his methods than most in the space, Johnson shares his entire regimen—biomarker testing, structured nutrition, sleep optimization, exercise programming, and supplement protocols—across his social channels and website. Though many experts have argued that the core practices are rooted in well-established health principles that probably don’t require seven figures to follow. What Immortals is selling is the infrastructure around them: the team, the AI, the tracking, the access, the exclusivity.
There’s nothing wrong with pushing the boundaries of preventive health. But a program that requires a personal assistant and a million-dollar commitment to participate isn’t advancing access to longevity. Instead, it’s reinforcing the belief that the most intensive version of it remains a luxury product for the very few.
Immortal’s waitlist is open now at blueprint.bryanjohnson.com.